| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA816753 | B | Binding affinity was evaluated on serine protease TPA. | 4 | ALA1131061 | single protein format | Scientific Literature | ||
| 2. | ALA816754 | B | Binding affinity was evaluated on serine protease TPA; Not Determined | 1 | ALA1131061 | single protein format | Scientific Literature | ||
| 3. | ALA816755 | B | Selectivity was evaluated as the binding affinity between thrombin versus TPA; Not determined | 1 | ALA1131061 | single protein format | Scientific Literature | ||
| 4. | ALA808446 | F | Percent activity regained after N2H4 treatment for Tissue plasminogen activator 19.4 nM) | 1 | ALA1125346 | assay format | Scientific Literature | ||
| 5. | ALA808447 | B | In vitro inhibitory concentration required to inhibit tissue plasminogen activator cleavage of the chromogenic substrate by 50%; Inactive | 3 | ALA1129832 | single protein format | Scientific Literature | ||
| 6. | ALA808448 | B | In vitro inhibitory concentration required to inhibit tissue plasminogen activator cleavage of the chromogenic substrate by 50%; Not determined | 1 | ALA1129832 | single protein format | Scientific Literature | ||
| 7. | ALA808450 | B | The compound was tested in vitro for its inhibitory activity against human t-PA enzyme, activity expressed as IC50 | 11 | ALA1133361 | single protein format | Scientific Literature | ||
| 8. | ALA881817 | B | Inhibition of human tissue plasminogen activator stimulator at 1 mM | Homo sapiens | 12 | ALA1136034 | single protein format | Scientific Literature | |
| 9. | ALA808451 | B | Ability to inhibit human tissue plasminogen activator stimulator at concentration of 1 uM | 5 | ALA1136034 | single protein format | Scientific Literature | ||
| 10. | ALA808452 | B | Ability to inhibit human tissue plasminogen activator stimulator at concentration of 1 uM | 1 | ALA1135370 | single protein format | Scientific Literature | ||
| 11. | ALA808453 | B | Ability to inhibit human tissue plasminogen activator stimulator at concentration of 100 uM | 1 | ALA1136034 | single protein format | Scientific Literature | ||
| 12. | ALA808454 | B | Ability to inhibit human tissue plasminogen activator stimulator at concentration of 1 mM | 2 | ALA1136034 | single protein format | Scientific Literature | ||
| 13. | ALA808455 | B | Ability to inhibit human tissue plasminogen activator stimulator at concentration of 30 uM | 1 | ALA1136034 | single protein format | Scientific Literature | ||
| 14. | ALA808456 | B | Ability to inhibit tissue plasminogen activator (quadratech) and S-2444 as substrate at concentration of 1 mM | 10 | ALA1135370 | single protein format | Scientific Literature | ||
| 15. | ALA808457 | B | Ability to inhibit tissue plasminogen activator (quadratech) and S-2444 as substrate at concentration of 300 uM | 1 | ALA1135370 | single protein format | Scientific Literature | ||
| 16. | ALA808458 | B | Maximum percent inhibition by the compound was determined against Tissue plasminogen activator (19.4 nM) | 3 | ALA1125346 | single protein format | Scientific Literature | ||
| 17. | ALA808459 | B | Maximum percent inhibition persists was determined against Tissue plasminogen activator (19.4 nM) | 1 | ALA1125346 | single protein format | Scientific Literature | ||
| 18. | ALA808460 | B | Inhibition against Tissue plasminogen activator at 1 mM | 18 | ALA1125001 | single protein format | Scientific Literature | ||
| 19. | ALA808461 | B | Inhibitory activity against the human tissue plasminogen activator | 5 | ALA1131990 | single protein format | Scientific Literature | ||
| 20. | ALA808462 | B | Ability to inhibit Tissue plasminogen activator using human Tissue plasminogen activator (quadratech) and S-2444 as substrate | 1 | ALA1135370 | single protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!